BSE Live
Nov 14, 16:01Prev. Close
130.10
Open Price
138.45
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 14, 15:50Prev. Close
130.38
Open Price
129.90
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
130.46 (29)
| Profit & Loss account of Indo US Bio-Tech (in Rs. Cr.) | Mar 22 | Mar 21 | Mar 20 | |
| 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||
| Revenue From Operations [Gross] | 50.06 | 40.11 | 39.76 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 50.06 | 40.11 | 39.76 | |
| Total Operating Revenues | 50.06 | 40.11 | 39.76 | |
| Other Income | 0.18 | 0.04 | 0.01 | |
| Total Revenue | 50.24 | 40.15 | 39.77 | |
| EXPENSES | ||||
| Cost Of Materials Consumed | 0.00 | 0.00 | 0.00 | |
| Purchase Of Stock-In Trade | 2.18 | 2.46 | 2.81 | |
| Operating And Direct Expenses | 45.20 | 25.11 | 26.68 | |
| Changes In Inventories Of FGWIP And Stock In Trade | -11.21 | -2.32 | 1.64 | |
| Employee Benefit Expenses | 0.71 | 0.52 | 0.57 | |
| Finance Costs | 1.18 | 1.17 | 0.85 | |
| Depreciation And Amortisation Expenses | 0.45 | 0.26 | 0.21 | |
| Other Expenses | 6.42 | 9.02 | 4.12 | |
| Total Expenses | 44.93 | 36.22 | 36.90 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 5.31 | 3.93 | 2.87 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 5.31 | 3.93 | 2.87 | |
| Tax Expenses-Continued Operations | ||||
| Current Tax | 0.38 | 0.00 | 0.22 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.03 | -0.33 | 0.08 | |
| Other Direct Taxes | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 0.25 | -0.97 | 0.33 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 5.06 | 4.90 | 2.54 | |
| Profit/Loss From Continuing Operations | 5.06 | 4.90 | 2.53 | |
| Profit/Loss For The Period | 5.06 | 4.90 | 2.53 | |
| Minority Interest | 0.00 | 0.00 | 0.00 | |
| Consolidated Profit/Loss After MI And Associates | 5.06 | 4.90 | 2.53 | |
| OTHER ADDITIONAL INFORMATION | ||||
| EARNINGS PER SHARE | ||||
| Basic EPS (Rs.) | 8.00 | 8.00 | 4.00 | |
| Diluted EPS (Rs.) | 8.00 | 8.00 | 4.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||
| Equity Share Dividend | 0.15 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 |
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
17.02.2025
Indo US Bio-Tec Standalone December 2024 Net Sales at Rs 23.56 crore, up 6.56% Y-o-Y
13.08.2024
Indo US Bio-Tec Standalone June 2024 Net Sales at Rs 24.72 crore, up 29.12% Y-o-Y
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
17.02.2025
Indo US Bio-Tec Standalone December 2024 Net Sales at Rs 23.56 crore, up 6.56% Y-o-Y
13.08.2024
Indo US Bio-Tec Standalone June 2024 Net Sales at Rs 24.72 crore, up 29.12% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017